Aspheric Monofocal Intraocular Lens in Pediatric Patients
NCT ID: NCT06153745
Last Updated: 2024-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13 participants
OBSERVATIONAL
2023-01-01
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Outcomes and Contrast Sensitivity in Patients Implanted With Tecnis Eyhance Intraocular Lens
NCT04800887
Visual Performance With a Hydrophobic Aspheric Monofocal IOL
NCT03819582
ICL and LASIK for Hyperopic Astigmatism
NCT06742541
Multifocal vs Monofocal IOL in Congenital Cataract Surgery
NCT04872829
Comparison of Two Aspheric Intraocular Lenses for Micro-monovision
NCT05531110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tecnis Eyhance ICB00 intraocular lens (Johnson&Johnson Vision, Santa Ana, California USA)
pediatric cataract surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* systemic diseases
6 Years
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Luca Buzzonetti
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luca Buzzonetti
Head of Ophthalmology Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luca Buzzonetti
Role: PRINCIPAL_INVESTIGATOR
Bambino Gesù Children's Hospital, Rome, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Luca Buzzonetti
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BG123
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.